DK0693933T3 - Fremgangsmåder og præparater til forsinkelse eller forebyggelse af udvikling af autoimmune sygdomme - Google Patents

Fremgangsmåder og præparater til forsinkelse eller forebyggelse af udvikling af autoimmune sygdomme

Info

Publication number
DK0693933T3
DK0693933T3 DK94914804T DK94914804T DK0693933T3 DK 0693933 T3 DK0693933 T3 DK 0693933T3 DK 94914804 T DK94914804 T DK 94914804T DK 94914804 T DK94914804 T DK 94914804T DK 0693933 T3 DK0693933 T3 DK 0693933T3
Authority
DK
Denmark
Prior art keywords
autoimmune diseases
methods
delaying
preparations
development
Prior art date
Application number
DK94914804T
Other languages
English (en)
Inventor
Noel K University Of Maclaren
Andrew Muir
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Application granted granted Critical
Publication of DK0693933T3 publication Critical patent/DK0693933T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94914804T 1993-04-16 1994-04-15 Fremgangsmåder og præparater til forsinkelse eller forebyggelse af udvikling af autoimmune sygdomme DK0693933T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/048,979 US5891435A (en) 1993-04-16 1993-04-16 Methods and compositions for delaying or preventing the onset of autoimmune disease
PCT/US1994/004179 WO1994023737A1 (en) 1993-04-16 1994-04-15 Methods and compositions for delaying or preventing the onset of autoimmune disease

Publications (1)

Publication Number Publication Date
DK0693933T3 true DK0693933T3 (da) 2002-10-21

Family

ID=21957455

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94914804T DK0693933T3 (da) 1993-04-16 1994-04-15 Fremgangsmåder og præparater til forsinkelse eller forebyggelse af udvikling af autoimmune sygdomme

Country Status (8)

Country Link
US (1) US5891435A (da)
EP (1) EP0693933B1 (da)
JP (1) JP3001638B2 (da)
AT (1) ATE219683T1 (da)
CA (1) CA2160543C (da)
DE (1) DE69430868T2 (da)
DK (1) DK0693933T3 (da)
WO (1) WO1994023737A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094597B1 (en) 1994-05-20 2006-08-22 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
US5773570A (en) * 1994-05-20 1998-06-30 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
EP0835129B1 (en) * 1995-06-30 2003-10-29 Novo Nordisk A/S Prevention of a disease having the characteristics of diabetes
US20020098194A1 (en) * 1996-03-21 2002-07-25 Paul V. Lehmann Methods for inducing immunity
EP1045860A2 (en) * 1998-01-08 2000-10-25 William Clifford Duckworth Methods and compositions for treating and diagnosing insulin related disorders
EP1094828A4 (en) * 1998-05-07 2005-01-26 Univ California USE OF TARGETED, NEGLIGATED TISSUE ANTIGENS TO MODULATE IMMUNE REACTIONS
US7030098B2 (en) 1999-03-12 2006-04-18 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for treatment of autoimmune disease
EP1168923B1 (en) * 1999-03-12 2005-11-02 The Board Of Trustees Of The Leland Stanford Junior University Dna vaccination for treatment of autoimmune disease
US6884785B2 (en) * 1999-06-17 2005-04-26 The Scripps Research Institute Compositions and methods for the treatment or prevention of autoimmune diabetes
US20070259007A1 (en) * 1999-10-19 2007-11-08 Kruzel Marian L Lactoferrin: an adjuvant for vaccines
AU1600401A (en) * 1999-11-12 2001-06-06 Chinese University Of Hong Kong, The Malaria vaccine
US7608683B2 (en) * 2000-08-09 2009-10-27 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
US6989146B2 (en) * 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
BR0115246A (pt) 2000-11-01 2005-04-26 Univ California Peptìdeos imunomoduladores derivados de proteìnas de choque e seu uso
KR100729645B1 (ko) * 2000-12-29 2007-06-18 주식회사 녹십자홀딩스 글루타민산 데카르복실라제를 코딩하는 유전자가 삽입된재조합 백시니아 바이러스 및 이를 포함하는 제 1형당뇨병 예방 백신
US20030045467A1 (en) * 2001-01-05 2003-03-06 Tihamer Orban Autoantigen composition
WO2004098645A1 (en) * 2003-05-12 2004-11-18 Tolerogen, Ltd. Immunoglobulin conjugates of autoantigens and their use in the prevention of disease
WO2007127787A2 (en) * 2006-04-25 2007-11-08 Joslin Diabetes Center, Inc. Insulin autoantigen-specific regulatory cd4+ t cells
AU2007281911B2 (en) 2006-08-04 2014-02-06 Beth Israel Deaconess Medical Center Inhibitors of pyruvate kinase and methods of treating disease
JP2011503232A (ja) 2007-11-20 2011-01-27 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 免疫応答の調節
US20130109672A1 (en) 2010-04-29 2013-05-02 The United States Of America,As Represented By The Secretary, Department Of Health And Human Service Activators of human pyruvate kinase
US9821035B2 (en) 2012-08-22 2017-11-21 Regimmune Corporation Preparation for preventing or treating type I diabetes
EP3033106A1 (en) * 2013-08-14 2016-06-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Immunoadjuvant compositions and uses thereof
EP3274053A4 (en) * 2015-03-23 2018-12-05 The Brigham and Women's Hospital, Inc. Tolerogenic nanoparticles for treating diabetes mellitus

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
US4464363A (en) * 1979-12-20 1984-08-07 Merck & Co., Inc. Ajuvants for rectal delivery of drug substances
ZA808097B (en) * 1980-12-29 1982-01-27 Lilly Co Eli Novel insulin formulations
JPS58189121A (ja) * 1982-04-30 1983-11-04 Ajinomoto Co Inc インシユリン投与賦活剤
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
SU1624511A1 (ru) * 1989-02-14 1991-01-30 Донецкий государственный медицинский институт им.М.Горького Способ моделировани сахарного диабета
CA2063414A1 (en) * 1989-06-19 1990-12-20 Richard A. Young Vector-mediated genomic insertion and expression of dna in bcg
FI920139A0 (fi) * 1989-07-14 1992-01-13 Autoimmune Inc Foerfaranden foer behandling och foerfindrande av autoimmun uveoretinitis hos daeggdjur.
HUT61896A (en) * 1990-03-02 1993-03-29 Autoimmune Inc Process for producing orally administrable pharmaceutical compositions comprising autoantigenes, suitable for improving down-control of autoimmune diseases
IL165071A (en) * 1990-03-30 2008-06-05 Autoimmune Inc A peptide with the ability to stimulate a subset of T cells from multiple sclerosis patients
US5512447A (en) * 1990-09-07 1996-04-30 The Regents Of The University Of California Methods for the diagnosis and treatment of diabetes
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
WO1994012529A1 (en) * 1992-12-03 1994-06-09 The Regents Of The University Of California Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
US5725860A (en) * 1994-03-07 1998-03-10 Auckland Uniservices Limited Method for reducing the risk of developing diabetes

Also Published As

Publication number Publication date
US5891435A (en) 1999-04-06
JP3001638B2 (ja) 2000-01-24
JPH08508036A (ja) 1996-08-27
EP0693933B1 (en) 2002-06-26
DE69430868T2 (de) 2003-01-30
EP0693933A1 (en) 1996-01-31
CA2160543A1 (en) 1994-10-27
DE69430868D1 (de) 2002-08-01
ATE219683T1 (de) 2002-07-15
CA2160543C (en) 2002-07-30
WO1994023737A1 (en) 1994-10-27

Similar Documents

Publication Publication Date Title
DE69430868D1 (de) Verfahren und zubereitungen zur verzoegerung oder vorbeugung von autoimmun krankheiten
ATE415173T1 (de) Pan dr-bindeproteinen zur erhöhung der immunantwort
NO20101441L (no) Tolerogent peptid og farmasoytisk preparat inneholdende det samme
BG102714A (en) Pharmaceutical composition for immunomodulation based on peptides and adjuvants
DK0427347T3 (da) Syntetiske peptider, der kan anvendes som universelle bærere til fremstilling af immunogene konjugater, og anvendelse deraf til udvikling af syntetiske vacciner
GB2303855B (en) Helicobacter pylori antigenic protein preparation and immunoassays
ES2074950A1 (es) Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
ATE314393T1 (de) Verzögerte freigabe von insulinotropin (glp-1)
KR970706842A (ko) 아실화된 인슐린 동족체(Acylated Insulin Analogs)
EP0992580A3 (en) Immunodominant human T-cell epitopes of Hepatitis C virus
WO1990006696A3 (en) Meningococcal class 1 outer-membrane protein vaccine
NO993979L (no) FremgangsmÕte for Õ forhindre og forsinke starten pÕ Alzheimer's sykdom og sammensetning derfor
EP0608261A4 (en) COMPOSITION OF AN IMMUNREACTIVE HEPATITIS C VIRUS POLYPEPTIDE.
WO1993000365A3 (en) Hepatitis c virus (hcv) polypeptides
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
DK395689A (da) Pharmaceutisk tilberedning til behandling af diabetes mellitus
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
EP0342860A3 (en) Novel protein, sequences containing the gene therefore, vectors, methods of preparation and use
WO1994023737B1 (en) Methods and compositions for delaying or preventing the onset of autoimmune disease
SE8204874D0 (sv) Farmaceutiska preparat, innefattande humant insulin och humant proinsulin
NO952336L (no) Insulin analoger
OA08749A (fr) Vaccins dont l'épitope caractéristique est incorporé dans une protéine de picornavirus, notamment de poliovirus.
SE8204873D0 (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
DK148085C (da) Dipeptidet pyrglu-his(2,4-dinitrophenyl)-oh og fremgangsmaade til fremstilling af lh-rh og lh-rh-analoge peptider under anvendelse af dette dipeptid